879013184	879013184	CD	B-NP	O
|	|	NN	I-NP	O
IPBH	IPBH	NN	I-NP	O
|	|	NN	I-NP	O
42501930	42501930	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
555532	555532	CD	B-NP	O
|	|	CC	I-NP	O
3/4/1996	3/4/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/4/1996	3/4/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/13/1996	3/13/1996	CD	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
UNSTABLE	UNSTABLE	NN	B-NP	O
ANGINA	ANGINA	NN	I-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

NON-INSULIN-DEPENDENT	NON-INSULIN-DEPENDENT	NNP	B-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
,	,	,	O	O
DIET	DIET	NNP	B-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

NASAL	NASAL	NNP	B-NP	O
POLYPS	POLYPS	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Ulses	Ulses	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
74-year-old	74-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
1995	1995	CD	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
,	,	,	I-NP	O
700	700	CD	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
199	199	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
infarction	infarction	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
TPA	TPA	NN	B-NP	O
at	at	IN	B-PP	O
Netla	Netla	NNP	B-NP	O
Ainor	Ainor	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
January	January	NNP	B-NP	O
1995	1995	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Cerri	Cerri	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
with	with	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
angioplasty	angioplasty	NN	I-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
LV	LV	NN	I-NP	O
gram	gram	NN	I-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
OM1	OM1	NN	I-NP	O
lesion	lesion	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
angioplastied	angioplastie	VBN	I-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
53	53	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
subsequently	subsequently	RB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
without	without	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Approximately	Approximately	RB	B-ADVP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Vasotec	Vasotec	NNP	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Cozaar	Cozaar	NNP	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Niacin	Niacin	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Pravachol	Pravachol	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
having	have	VBG	I-VP	O
some	some	DT	B-NP	O
intermittent	intermittent	JJ	I-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
both	both	CC	B-PP	O
at	at	IN	I-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
without	without	IN	B-PP	O
current	current	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
available	available	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
heartbeat	heartbeat	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
stopped	stop	VBD	B-VP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
Pravachol	Pravachol	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
changed	change	VBD	B-VP	O
from	from	IN	B-PP	O
Cozaar	Cozaar	NNP	B-NP	O
to	to	TO	B-PP	O
Vasotec	Vasotec	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increased	increase	VBN	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
both	both	CC	B-PP	O
at	at	IN	I-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
2	2	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
a	a	DT	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
dull	dull	JJ	I-NP	O
ache	ache	NN	I-NP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
associated	associated	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
associate	associate	VB	I-VP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
particular	particular	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
happen	happen	VB	I-VP	O
sitting	sit	VBG	I-VP	O
still	still	RB	B-ADVP	O
or	or	CC	O	O
with	with	IN	B-PP	O
activity	activity	NN	B-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
particular	particular	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
today	today	NN	B-NP	O
's	's	POS	B-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
climbed	climb	VBN	I-VP	O
two	two	CD	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
developed	develop	VBD	B-VP	O
this	this	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
lasted	last	VBD	B-VP	O
for	for	IN	B-PP	O
10-15	10-15	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
rest	rest	NN	B-NP	O
or	or	CC	O	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
of	of	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
arrived	arrive	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	B-DNA
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
gone	go	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
230	230	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
nifedipine	nifedipine	NN	B-NP	O
times	time	NNS	I-NP	O
one	one	CD	B-NP	O
and	and	CC	I-NP	O
IV	IV	CD	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
which	which	WDT	B-NP	O
brought	bring	VBD	B-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
140/90	140/90	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
times	time	NNS	I-NP	O
five	five	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
controlled	control	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
nasal	nasal	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
and	and	CC	I-NP	O
Toprol	Toprol	NNP	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
father	father	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
48	48	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
mother	mother	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
80	80	CD	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
retired	retire	VBN	I-VP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
warehouse	warehouse	NN	I-NP	O
owner	owner	NN	I-NP	O
and	and	CC	I-NP	O
shipping	shipping	NN	I-NP	O
business	business	NN	I-NP	O
owner	owner	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
occasionally	occasionally	RB	B-ADVP	O
will	will	MD	B-VP	O
bicycle	bicycle	VB	I-VP	O
eight	eight	CD	B-NP	O
miles	mile	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
or	or	CC	O	O
be	be	VB	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
six	six	CD	B-NP	O
miles	mile	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
done	do	VBN	I-VP	O
this	this	DT	B-NP	O
since	since	IN	B-PP	O
this	this	DT	B-NP	O
summer	summer	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
97.1	97.1	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/70	140/70	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
68	68	CD	I-NP	O
,	,	,	O	O
saturation	saturation	NN	B-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
extraocular	extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
bradycardic	bradycardic	JJ	B-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
organomegaly	organomegaly	NN	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	JJ	B-ADJP	O
negative	negative	JJ	I-ADJP	O
per	per	IN	B-PP	O
Emergency	Emergency	NNP	B-NP	O
Department	Department	NNP	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
DP	DP	NN	B-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
,	,	,	O	O
grossly	grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
43	43	CD	B-NP	O
intervals	interval	NNS	I-NP	O
0.133	0.133	CD	I-NP	O
,	,	,	I-NP	O
0.121	0.121	CD	I-NP	O
,	,	,	I-NP	O
0.483	0.483	CD	I-NP	O
,	,	,	O	O
axis	axis	NN	B-NP	O
48	48	CD	I-NP	O
,	,	,	O	O
interventricular	interventricular	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
delay	delay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
small	small	JJ	B-NP	O
ST	ST	JJ	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
V4	V4	NN	B-NP	O
and	and	CC	I-NP	O
V5	V5	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mm	mm	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
opacity	opacity	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
versus	versus	IN	B-PP	O
first	first	JJ	B-NP	O
rib	rib	NN	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
was	be	VBD	B-VP	O
141	141	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.1	5.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
12	12	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
81	81	CD	I-NP	O
,	,	,	O	O
LDH	LDH	NN	B-NP	B-protein
298	298	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
0	0	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
CK	CK	NN	B-NP	B-protein
96	96	CD	I-NP	I-protein
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
74-year-old	74-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	I-NP	O
OM1	OM1	NN	I-NP	O
branches	branch	NNS	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
severe	severe	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
causing	cause	VBG	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
nicely	nicely	RB	B-ADVP	O
initially	initially	RB	I-ADVP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
Vasotec	Vasotec	NNP	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
and	and	CC	I-ADVP	O
then	then	RB	I-ADVP	O
discontinued	discontinue	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
down	down	RP	B-PRT	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
Imdur	Imdur	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
losartan	losartan	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
with	with	IN	B-PP	O
improved	improve	VBN	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
apparently	apparently	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
Norvasc	Norvasc	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
so	so	RB	O	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
tried	try	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
September	September	NNP	I-NP	O
1996	1996	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
36/8	36/8	CD	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
40/16	40/16	CD	I-NP	O
,	,	,	O	O
mean	mean	NN	B-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
195/36	195/36	CD	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
5.3	5.3	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	B-protein
index	index	NN	I-NP	I-protein
2.5	2.5	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
first	first	JJ	I-NP	O
diagonal	diagonal	JJ	I-NP	O
branch	branch	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Circumflex	Circumflex	NN	B-NP	O
was	be	VBD	B-VP	O
okay	okay	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
25	25	CD	I-NP	O
%	%	NN	I-NP	O
serial	serial	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
3.0	3.0	CD	I-NP	O
micron	micron	NN	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
down	down	IN	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
residual	residual	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Ticlid	Ticlid	NNP	B-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
losartan	losartan	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Ticlid	Ticlid	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Eisentrout	Eisentrout	NNP	I-NP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
DARRYL	DARRYL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
DAGNER	DAGNER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ZS93	ZS93	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PATRICK	PATRICK	NNP	B-NP	O
N.	N.	NNP	I-NP	O
BOSHEERS	BOSHEERS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BU9	BU9	NNP	I-NP	O
VJ885/8413	VJ885/8413	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
40763	40763	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

G9FN108FWV	G9FN108FWV	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/17/96	4/17/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/25/96	8/25/96	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CORDELL	CORDELL	NNP	B-NP	O
A.	A.	NNP	I-NP	O
ANNAND	ANNAND	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
IL2	IL2	NNP	I-NP	B-protein

